Technical Analysis for BSX - Boston Scientific Corporation

Grade Last Price % Change Price Change
grade D 39.91 -2.85% -1.17
BSX closed down 2.85 percent on Tuesday, February 25, 2020, on 1.2 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BSX trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Multiple of Ten Bearish Other 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 200 DMA Bearish -2.85%
MACD Bearish Signal Line Cross Bearish -2.85%
Below Lower BB Weakness -2.85%
Gapped Down Weakness -2.85%
Lower Bollinger Band Touch Weakness -2.85%
20 DMA Resistance Bearish -6.36%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; and implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker systems to treat heart failure. In addition, the company offers endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to diagnose and treat peripheral vascular disease. Further, it provides stone management products comprising ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons, and catheters to treat urinary stone disease and benign prostatic hyperplasia; and mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices for women's health. Additionally, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company was founded in 1979 and is headquartered in Natick, Massachusetts.
Medicine Clinical Medicine Diseases Radio Frequency Medical Technology Catheters Catheter Ultrasound Interventional Radiology Heart Failure Chronic Pain Prosthetics Interventional Cardiology Cardiac Electrophysiology Benign Prostatic Hyperplasia Biomedical Engineering Coronary Artery Disease Peripheral Vascular Disease Markets Medical Devices Angiography Angioplasty Lithotripsy Neuromodulation Products Percutaneous Transluminal Coronary Angioplasty Treatment Of Coronary Artery Disease

Is BSX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 46.6
52 Week Low 34.34
Average Volume 7,316,907
200-Day Moving Average 41.88
50-Day Moving Average 43.77
20-Day Moving Average 42.43
10-Day Moving Average 42.08
Average True Range 0.94
ADX 24.14
+DI 14.84
-DI 36.47
Chandelier Exit (Long, 3 ATRs ) 41.37
Chandelier Exit (Short, 3 ATRs ) 42.54
Upper Bollinger Band 44.10
Lower Bollinger Band 40.76
Percent B (%b) -0.25
BandWidth 7.88
MACD Line -0.61
MACD Signal Line -0.45
MACD Histogram -0.1506
Fundamentals Value
Market Cap 54.77 Billion
Num Shares 1.37 Billion
EPS 0.56
Price-to-Earnings (P/E) Ratio 71.27
Price-to-Sales 4.54
Price-to-Book 5.46
PEG Ratio 2.16
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.33
Resistance 3 (R3) 42.53 41.92 41.92
Resistance 2 (R2) 41.92 41.31 41.82 41.79
Resistance 1 (R1) 40.92 40.93 40.62 40.72 41.65
Pivot Point 40.31 40.31 40.16 40.21 40.31
Support 1 (S1) 39.31 39.70 39.01 39.11 38.17
Support 2 (S2) 38.70 39.32 38.60 38.03
Support 3 (S3) 37.70 38.70 37.90
Support 4 (S4) 37.50